These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12927915)

  • 1. Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis.
    De BK; Majumdar D; Das D; Biswas PK; Mandal SK; Ray S; Bandopadhyay K; Das TK; Dasgupta S; Guru S
    J Hepatol; 2003 Sep; 39(3):315-9. PubMed ID: 12927915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites.
    Pozzi M; Carugo S; Boari G; Pecci V; de Ceglia S; Maggiolini S; Bolla GB; Roffi L; Failla M; Grassi G; Giannattasio C; Mancia G
    Hepatology; 1997 Nov; 26(5):1131-7. PubMed ID: 9362352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
    Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
    J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
    Sarin SK; Sethi KK; Nanda R
    Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension.
    Sarin SK; Guptan RC; Malhotra S
    J Assoc Physicians India; 2002 Apr; 50():518-22. PubMed ID: 12164401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cardiac function in cirrhotic patients with and without ascites.
    Valeriano V; Funaro S; Lionetti R; Riggio O; Pulcinelli G; Fiore P; Masini A; De Castro S; Merli M
    Am J Gastroenterol; 2000 Nov; 95(11):3200-5. PubMed ID: 11095342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal venous system measurements in portal hypertension.
    Lafortune M; Marleau D; Breton G; Viallet A; Lavoie P; Huet PM
    Radiology; 1984 Apr; 151(1):27-30. PubMed ID: 6701328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.
    Ruíz-del-Árbol L; Achécar L; Serradilla R; Rodríguez-Gandía MÁ; Rivero M; Garrido E; Natcher JJ
    Hepatology; 2013 Nov; 58(5):1732-41. PubMed ID: 23703953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
    ONeill JP; Clifford CS; Nolan NP; McCormick PA
    Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cirrhotic portal fibrosis associated with pulmonary arteriovenous communication and pulmonary arterial hypertension.
    Chongsrisawat V; Vivatvakin B; Suwangool P; Vajragupta L; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):76-9. PubMed ID: 9740273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices due to cirrhosis of liver, non-cirrhotic portal fibrosis and extrahepatic obstruction: comparison of results.
    Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():198-200. PubMed ID: 2519051
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary function tests in cirrhotic and non-cirrhotic portal hypertension.
    Nagral A; Kolhatkar VP; Bhatia SJ; Taskar VS; Abraham P
    Indian J Gastroenterol; 1993 Apr; 12(2):36-40. PubMed ID: 8340139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of changes in central hemodynamics and hormonal systems of its regulation on the etiology of portal hypertension complications in patients with liver cirrhosis].
    Tsykin DB; Iampol'skaia LI; Borisov AE; Tsykina GA; Shcherba IuV; Oktiabr'skaia IN; Levina AE
    Klin Med (Mosk); 1995; 73(4):99. PubMed ID: 7474848
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathology of idiopathic non-cirrhotic portal hypertension.
    Guido M; Sarcognato S; Sacchi D; Colloredo G
    Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension.
    Celtik C; Durmaz O; Oner N; Yavuz T; Gökce S; Aydogan A; Nisli K; Emiroglu HH; Ömeroglu RE; Sökücü S
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):177-81. PubMed ID: 25250684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatopulmonary Syndrome in children: a comparative study of non-cirrhotic vs. cirrhotic portal hypertension.
    Borkar VV; Poddar U; Kapoor A; Ns S; Srivastava A; Yachha SK
    Liver Int; 2015 Jun; 35(6):1665-72. PubMed ID: 25351435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients.
    Kim TY; Jeong WK; Sohn JH; Kim J; Kim MY; Kim Y
    Liver Int; 2015 Nov; 35(11):2416-24. PubMed ID: 25875718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.